Brief Article
Copyright ©2010 Baishideng.
World J Gastroenterol. Jun 28, 2010; 16(24): 3056-3062
Published online Jun 28, 2010. doi: 10.3748/wjg.v16.i24.3056
Table 1 Reasons for adopting combination therapy n (%)
Combination group (n = 19)
Bilobar disease14 (73.6)
Proximity to major vessel or bile duct5 (26.3)
Dense adhesion3 (15.8)
Large resection required for small tumors5 (26.3)
ICG rate at 15 min > 14.4%5 (26.3)
Low platelet count (< 100 × 109/L)3 (15.8)
Severe cirrhosis9 (47.4)